Skip to content
GuideZone

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Deal Over Information Fears

Medical funding illustration
The proposed US funding would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (£272m) over five years over Washington's demand for confidential data.

This move became public following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "lopsided".

A government spokesperson later explained that the United States was demanding access to health data for scientific study and commercial purposes while refused to share the resulting advantages from any future medical innovations.

"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has called for further talks to secure a deal agreeable to all parties so the nation's vital HIV treatment initiative can proceed.

Broader Background

Zimbabwe's decision follows a comparable situation in Kenya, where a high court blocked a similar deal with the US following legal challenges were raised about the safety of Kenyans' health data.

Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had overseen aid for the American government, but Trump argued its spending was "wasteful" and his administration was seeking direct bilateral deals to boost transparency and responsibility.

Based on statements, 16 nations in Africa have to date signed these new agreements, representing over $18.3bn in new funding.

Specifics of the Declined Deal

The funds for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.

"In essence, our nation would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our population if a new health crisis arise."

Sovereignty and International Frameworks

Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems previously set up via the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.

"This framework is intended to guarantee that when a country provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."

The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We encourage ongoing discussions with our US partners on how subsequent co-operation could be arranged in a way that honours the sovereignty and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks must proceed given that much of the country's Aids initiatives depended on external financing.

"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it said.

The halted deal underscores the ongoing debate between accepting vital foreign assistance and protecting national sovereignty in an increasingly data-driven world.

About the author

Edward Lopez

A seasoned writer and lifestyle consultant with a passion for sharing actionable tips and personal growth strategies.

GuideZone

Type to search articles.